人民财讯9月16日电，云锋金融(00376.HK)在港交所公告，公司以先旧后新方式配售发行共1.91亿股新 股，配售价每股6.1港元，集资共约11.7亿港元。此次配售旨在扩大公司股东及资本基础，并增加公司股 份在市场的流动性。 ...

Core Viewpoint - Yunfeng Financial (00376) announced a placement of 191 million new shares at a price of HKD 6.1 per share, raising approximately HKD 1.17 billion to enhance its shareholder base and capital foundation, while increasing market liquidity [1] Group 1: Fundraising Details - The placement was conducted on a "old shares first, new shares later" basis, with the placement price representing a premium of about 16% over the average closing price of the previous five days and a premium of about 38% over the average closing price of the previous ten days [1] Group 2: Use of Proceeds - The raised funds will primarily be used for system facility upgrades, talent recruitment, and related capital needs, including the launch of comprehensive virtual asset trading services and virtual asset-related investment management services [1] Group 3: Future Vision - The company aims to continue promoting the deep integration of traditional finance and blockchain technology, with a vision to create a new generation Web3 financial service ecosystem, encapsulated in the slogan "Everything on the chain, linking the world" [1]

Core Viewpoint - Yunfeng Financial (00376) announced a placement of 191 million new shares at a price of HKD 6.1 per share, raising approximately HKD 1.17 billion to enhance its shareholder base and capital foundation, while increasing market liquidity [1] Group 1: Share Placement Details - The share placement was conducted on a "old shares first, new shares later" basis, with a premium of about 16% over the average closing price of the previous five days and a premium of about 38% over the average closing price of the previous ten days [1] Group 2: Financial and Business Development - The raised funds will be primarily used for system upgrades, talent recruitment, and related capital needs, including the launch of comprehensive virtual asset trading services and virtual asset-related investment management services [1] - The company aims to deepen the integration of traditional finance with blockchain technology, pursuing its vision of creating a new generation Web3 financial service ecosystem [1]

Core Viewpoint - Yunfeng Financial (00376) has announced a placement and subscription agreement involving the sale of 191 million shares at a price of HKD 6.10 per share, representing a discount of approximately 16.8% from the last closing price of HKD 7.33 [1] Group 1: Placement and Subscription Agreement - The seller, Jade Passion Limited, has agreed to sell shares, while the placement agent will act as the seller's agent to facilitate the purchase by at least six subscribers [1] - The placement price of HKD 6.10 per share is set below the market price, indicating a strategic move to attract investors [1] - If all shares are placed, they will represent approximately 4.95% of the existing issued share capital as of the announcement date, and about 4.71% of the enlarged issued share capital post-subscription [1] Group 2: Financial Implications - The estimated total proceeds from the placement are approximately HKD 1.17 billion, with net proceeds expected to be around HKD 1.15 billion [1]

智通财经APP讯，云锋金融(00376)发布公告，于2025年9月16日(交易时段前)，公司、卖方Jade Passion Limited及配售代理订立配售及认购协议，据此：(i)卖方已同意出售，而配售代理已个别(非共同或共同 及个别)同意担任卖方之代理，尽力促使不少于六名承配人按每股配售股份6.10港元的配售价购买1.91亿 股销售股份;及(ii)卖方已有条件同意认购，而公司已有条件同意根据一般授权按每股配售股份6.10港元 的配售价向卖方配发及发行认购股份(该等认购股份数目应与配售代理根据配售及认购协议实际配售的 销售股份数目相同)。配售价每股6.10港元较股份于最后交易日于联交所所报之收市价每股7.33港元折让 约16.8%。 假设销售股份悉数配售，销售股份占本公告日期现有已发行股本约4.95%，并占紧随认购截止后配发及 发行认购股份而扩大的已发行股本约4.71%。估计所得款项总额及所得款项净额分别约为11.7亿港元及 约11.5亿港元。 ...

Core Viewpoint - Yunfeng Financial (00376.HK) has entered into a placement and subscription agreement to sell and issue shares at a price of HKD 6.10 per share, which represents a discount of approximately 16.8% from the last closing price of HKD 7.33 [1][2] Group 1 - The seller, Jade Passion Limited, has agreed to sell 191.3 million shares, which represents about 4.95% of the existing issued share capital as of the announcement date [2] - The estimated total gross proceeds from the subscription are approximately HKD 1.17 billion, with net proceeds expected to be around HKD 1.15 billion [2] - The company plans to allocate approximately 70% of the net proceeds for system facility upgrades, talent recruitment, and related capital needs, including the launch of comprehensive virtual asset trading services and related investment management services [2] Group 2 - Approximately 30% of the net proceeds will be used for general working capital to cover expenses incurred in the daily operations of the group [2]

不得在美國境內分發 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或 因倚賴該等內容而引致的任何損失承擔任何責任。 本公告僅作資訊用途，並非於美國或任何其他司法權區出售或收購證券的邀請或要約或要約 購買證券的招攬，未根據任何該等司法權區的證券法登記或獲批准而於上述司法權區進行的 相關邀請、要約、收購、招攬或出售均屬違法。 本公告或其任何內容概不構成任何合約或承諾的基礎。本公告及其任何副本不得帶入美國或 於美國分發。本公告所述證券並無亦不會根據 1933 年美國證券法（經修訂）或向美國任何州或其 他司法權區的任何證券監管機構登記，且不得於美國提呈發售或出售，惟獲得 1933 年美國證券 法（經修訂）及適用州或地方證券法登記規定的適用豁免，或屬不受 1933 年美國證券法（經修 訂）及適用州或地方證券法登記規定約束的交易則除外。任何於美國進行的證券公開發售將 以招股章程的方式進行。有關招股章程將包含有關本公司及其管理層的詳細信息及財務報表 。本公司不會於美國公開發售證券。 董事會欣然宣佈，於二零二五年 ...

Group 1 - The Hang Seng Index rose by 0.29%, gaining 75 points to reach 26,463 points, while the Hang Seng Tech Index increased by 1.11%. The early trading volume in Hong Kong was HKD 162 billion [1] - CRO concept stocks saw significant gains, with Kanglong Chemical (03759) rising over 8% due to accelerated clinical trial review and approval processes. Other notable performers included Zhaoyan New Drug (06127) up 7%, WuXi Biologics (02269) up 5.5%, and Kelaiying (06821) up 4.2% [1] Group 2 - Yaojie Ankang (02617) surged over 33% after being included in the Hong Kong Stock Connect list, effective from September 8 [2] - The lithium battery sector performed well, with Morgan Stanley issuing a positive report on CATL, as market attention shifts to lithium demand expectations for next year. Notable stock movements included Zhongxin Hang (03931) up 4%, CATL (03750) up 7%, and Ganfeng Lithium (01772) up 4% [2] Group 3 - Yunfeng Financial (00376) increased by over 19%, with its stock price doubling within the month following the approval of its virtual asset trading services [3] Group 4 - Ruipu Lanjun (00666) rose nearly 2%, driven by sustained high production levels at major battery manufacturers and a significant increase in the company's energy storage battery shipments [4] Group 5 - Hushang Ayi (02589) gained over 8% after being included in the Hong Kong Stock Connect list, with stable growth in store numbers during the first half of the year [5] - Brainstorm Cell Therapeutics-B (06681) saw a dramatic rise, initially up 83% to a record high, and closing up 36%, with a cumulative increase of over 130% since its inclusion in the Stock Connect list on September 8. The company is noted for developing the first medical-grade digital therapy product for cognitive disorders in China [5] Group 6 - Baiao Saitu-B (02315) increased by over 11% after signing an antibody selection rights evaluation agreement with Merck to advance antibody-drug conjugate lipid delivery solutions [6] Group 7 - Domestic property stocks collectively declined, with Shimao Group (00813) falling nearly 5% and Zhongliang Holdings (02772) dropping over 3% [7]

Core Viewpoint - Yunfeng Financial (00376) has seen its stock price increase by over 12%, achieving a doubling in value within the month, with a current price of 6.79 HKD and a trading volume of 217 million HKD [1] Group 1: Company Developments - On September 9, Yunfeng Financial announced that its wholly-owned subsidiary, Yunfeng Securities, received approval from the Hong Kong Securities and Futures Commission on September 8 to upgrade its existing Type 1 (Securities Trading) regulated activity license [1] - Following the upgrade, Yunfeng Securities will be able to provide virtual asset trading services for both retail and professional investors, allowing clients to trade digital assets directly on Yunfeng Financial's trading platform [1] Group 2: Strategic Partnerships and Investments - In early September, Yunfeng Financial announced a strategic partnership with Ant Digital Technology to jointly explore tokenization of real-world assets (RWA) and Web3 through the next-generation Layer 1 blockchain platform, Pharos [1] - The company’s board has approved the purchase of ETH in the open market as a reserve asset, with a total acquisition of 10,000 ETH at an investment amount of 44 million USD, fully funded by the company's internal cash reserves [1]

Core Viewpoint - Yunfeng Financial (00376) has seen its stock price double within the month, with a recent increase of over 12% [1] Group 1: Stock Performance - As of the latest update, Yunfeng Financial's stock price is reported at 6.79 HKD, with a trading volume of 217 million HKD [1] - The stock has experienced a 10.77% increase at the time of reporting [1] Group 2: Regulatory Approval - On September 9, Yunfeng Financial announced that its wholly-owned subsidiary, Yunfeng Securities, received approval from the Hong Kong Securities and Futures Commission on September 8 [1] - The approval allows Yunfeng Securities to upgrade its existing license for regulated activities in securities trading, enabling it to offer virtual asset trading services to retail and professional investors [1] Group 3: Strategic Partnerships and Investments - In early September, Yunfeng Financial announced a strategic partnership with Ant Digital Technology to explore tokenization of real-world assets (RWA) and Web3 through the new Layer1 blockchain platform, Pharos [1] - The company’s board has approved the purchase of ETH as a reserve asset, with a total acquisition of 10,000 ETH at an investment amount of 44 million USD, funded entirely from internal cash reserves [1]